Insider Transactions in Q1 2026 at Amicus Therapeutics, Inc. (FOLD)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jan 03 2026	David Michael Clark Chief People Officer	SELL Payment of exercise price or tax liability	Direct	18,498 -7.7%	$258,972 $14.27 P/Share
Jan 03 2026	Samantha Prout Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	12,240 -8.86%	$171,360 $14.27 P/Share
Jan 03 2026	Jeff Castelli Chief Development Officer	SELL Payment of exercise price or tax liability	Direct	23,102 -5.34%	$323,428 $14.27 P/Share

Jan 03 2026	Ellen Rosenberg Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	29,683 -6.01%	$415,562 $14.27 P/Share
Jan 02 2026	David Michael Clark Chief People Officer	SELL Payment of exercise price or tax liability	Direct	5,381 -2.19%	$75,334 $14.27 P/Share
Jan 02 2026	Samantha Prout Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	3,443 -2.43%	$48,202 $14.27 P/Share
Jan 02 2026	Jeff Castelli Chief Development Officer	SELL Payment of exercise price or tax liability	Direct	6,905 -1.57%	$96,670 $14.27 P/Share
Jan 02 2026	Ellen Rosenberg Chief Legal Officer	SELL Payment of exercise price or tax liability	Direct	13,426 -2.64%	$187,964 $14.27 P/Share

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

Receive news related to AMICUS THERAPEUTICS, INC.